30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Pathfinder Cell Therapy Inc (PFND)

Track

Stock chart
Ticker: PFND Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
PINE ELI
Vice President, CSO
1 purchase — total 1,440 USD
Buy 9 Dec 2008
Value US$2,508,178.97 | Price 51.78 | Shares 7,970
Buy 6 Jun 2008
Value US$3,026,032.39 | Price 482.35 | Shares 57,853
Buy 10 Oct 2007
Value US$62,900.00 | Price 0.74 | Shares 85,000
Buy 26 Sep 2007
Value US$7,200.00 | Price 0.72 | Shares 10,000
Buy 4 Jun 2007
Value US$1,700.00 | Price 1.00 | Shares 1,700
Buy 31 May 2007
Value US$3,220.00 | Price 0.92 | Shares 3,500
Planned sale 28 Mar 2007
Value US$1,224.00 | Price 1.02 | Shares 1,200
Planned sale 27 Mar 2007
Value US$7,725.00 | Price 1.03 | Shares 7,500
Planned sale 21 Feb 2007
Value US$396.72 | Price 0.76 | Shares 522
Buy 6 Oct 2006
Value US$38,564.16 | Price 0.34 | Shares 113,424
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2008-12-11 2008-12-09 B Purchase PINE ELI

Vice President, CSO

Officer
7,970 -15.3%
51.78
US$2,508,179 		7,970 -15.3% 51.78 US$2,508,179
2008-06-11 2008-06-06 B Purchase FRANKLIN RICHARD L

Chairman of the Board

Executive Director
57,853 -48.2%
482.35
US$3,026,032 		57,853 -48.2% 482.35 US$3,026,032
2007-10-11 2007-10-10 B Purchase FRANKLIN RICHARD L

Chairman of the Board

Executive Director
82,164 +1.0%
313.92
US$1,758,337 		82,164 +1.0% 313.92 US$1,758,337
2007-09-26 2007-09-26 B Purchase HICKEY ROBERT P

President,CEO,CFO

Executive Director
10,000 +4.0%
0.72
US$7,200 		10,000 +4.0% 0.72 US$7,200
2007-06-04 2007-06-04 B Purchase FRANKEL BARRY R Non-Executive Director
1,700 +48.6%
1.00
US$1,700 		1,700 +48.6% 1.00 US$1,700
2007-06-04 2007-05-31 B Purchase FRANKEL BARRY R Non-Executive Director
3,500 +inf%
0.92
US$3,220 		3,500 +inf% 0.92 US$3,220
2007-03-29 2007-03-28 PlS Planned sale CELANO EDWARD A Non-Executive Director
1,200 -1.9%
1.02
US$1,224 		1,200 -1.9% 1.02 US$1,224
2007-03-29 2007-03-27 PlS Planned sale CELANO EDWARD A Non-Executive Director
7,500 -10.7%
1.03
US$7,725 		7,500 -10.7% 1.03 US$7,725
2007-02-23 2007-02-21 PlS Planned sale CELANO EDWARD A Non-Executive Director
522 -0.8%
0.76
US$397 		522 -0.8% 0.76 US$397
2006-10-10 2006-10-06 B Purchase FRANKLIN RICHARD L

Chairman of the Board

Executive Director
113,424 +inf%
0.34
US$38,564 		113,424 +inf% 0.34 US$38,564
Explore more

More insider trading research around Pathfinder Cell Therapy Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America